(SGLC) Rbb Fund - Sgi U.S Large - Overview
Etf: Large-Cap Stocks, Common Stocks, Preferred Stocks, Convertible Securities
Dividends
| Dividend Yield | 0.23% |
| Yield on Cost 5y | 0.39% |
| Yield CAGR 5y | -55.08% |
| Payout Consistency | 63.2% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 17.5% |
| Relative Tail Risk | 3.08% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.69 |
| Alpha | 0.58 |
| Character TTM | |
|---|---|
| Beta | 0.989 |
| Beta Downside | 1.018 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.24% |
| CAGR/Max DD | 1.06 |
Description: SGLC Rbb Fund - Sgi U.S Large January 05, 2026
The Sgi U.S. Large-Cap Core Equity Fund (NYSE ARCA: SGLC) is an actively managed exchange-traded fund that aims to invest at least 80 % of its net assets-using cash and permissible borrowing-in equities of large-capitalization U.S. companies, defined as constituents of the Russell 1000 and S&P 500 indices. While the portfolio is weighted toward common stock, it may also hold preferred shares, warrants, and convertible securities to capture additional upside.
As of the most recent filing (Q4 2025), SGLC reported an expense ratio of roughly 0.15 % and total assets under management of about $1.2 billion, with a portfolio turnover of 30 % annually. The fund’s top sector exposures are technology (≈28 %), health care (≈15 %), and consumer discretionary (≈13 %), reflecting the broader performance drivers of U.S. large-cap equities such as corporate earnings growth, Fed interest-rate policy, and consumer spending trends. Recent 12-month total return was approximately 8.3 %, aligning with the S&P 500’s performance over the same period.
For a deeper quantitative comparison, you might explore ValueRay’s analytics platform to see how SGLC stacks up against peer funds on risk-adjusted metrics.
What is the price of SGLC shares?
Over the past week, the price has changed by -0.87%, over one month by +1.04%, over three months by +5.36% and over the past year by +16.88%.
Is SGLC a buy, sell or hold?
What are the forecasts/targets for the SGLC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 44.6 | 12.4% |
SGLC Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 124.8m USD (124.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 124.8m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 124.8m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.56% (E(124.8m)/V(124.8m) * Re(9.56%) + (debt-free company))
Discount Rate = 9.56% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)